MeCP2-deficient mice have reduced α4 and α6 nicotinic receptor mRNA and altered behavioral response to nicotinic agonists

This publication has 65 references indexed in Scilit:

• The Necessity of α4* Nicotinic Receptors in Nicotine-Driven Behaviors: Dissociation Between Reinforcing and Motor Effects of Nicotine
  Neuropsychopharmacology, 2011
• Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists
  British Journal of Pharmacology, 2011
• Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
  Nature, 2010
• MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
  Science, 2008
• The Story of Rett Syndrome: From Clinic to Neurobiology
  Neuron, 2007
• The Disease Progression of Mecp2 Mutant Mice Is Affected by the Level of BDNF Expression
  Neuron, 2006
• Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
  Nature Genetics, 2001
• TC-2559: A novel orally active ligand selective at neuronal acetylcholine receptors
  European Journal of Pharmacology, 2000
• Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
  Nature Genetics, 1999
• MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
  Cell, 1997